seed
Stage
About
Glen Clova Scientific develops a new generation of active biologic drugs using virus-like particle (VLP) technology to treat chronic inflammatory and autoimmune disorders, aiming to provide more effective and cost-efficient therapies compared to traditional biologics.
Explore Glen Clova Scientific's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.